Does Progyny Stock Lead The Pack? [Forbes]
Progyny, Inc. (PGNY)
Last progyny, inc. earnings: 3/5 04:06 pm
Check Earnings Report
Company Research
Source: Forbes
Its focused model has driven strong demand and set it apart in a niche that's expanding quickly within the healthcare sector. The stock has markedly outperformed its competitors during the last year, achieving a 90% return. But how does its growth and profitability compare to healthcare peers such as Stryker and Zimmer Biomet? An examination shows impressive revenue growth of 11.41% LTM and competitive free cash flow margins of 15.25% LTM. However, its operating margin of 6.77% LTM lags behind some of its larger competitors, and its valuation (P/E 40.78) is deemed moderate to high, indicating limited upside potential if growth decelerates. PGNY's operating margin of 6.8% falls short of SYK's 19.6%, highlighting the lower profitability of a service model compared to device sales. PGNY's revenue growth of 11.4% exceeds that of most competitors, reflecting strong demand for its fertility benefits, even though GMED shows superior growth. PGNY realized a gain of 94.8% (PE 40.8), su
Show less
Read more
Impact Snapshot
Event Time:
PGNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGNY alerts
High impacting Progyny, Inc. news events
Weekly update
A roundup of the hottest topics
PGNY
News
- Progyny (PGNY) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and ActionGlobeNewswire
- Progyny: Growth Has Returned (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Progyny (PGNY): Gauging Valuation After Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Progyny CEO buys $1.93M in company stock [Seeking Alpha]Seeking Alpha
PGNY
Earnings
- 11/6/25 - Beat
PGNY
Sec Filings
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 144
- PGNY's page on the SEC website